Harmonic today announced that Cignal TV, a leading pay-TV provider in the Philippines, has expanded its partnership with Harmonic to modernize channel origination, playout and disaster recovery ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

LONDON, May 14 (Reuters) - Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry grows that layoffs and policy changes at the ...

As a one-stop drug discovery solution provider, Viva Biotech embraced atomic-level perspective. Dr. Qian emphasized that Viva has over 15 years of experience in structure-based drug discovery ...

Shares of Septerna Inc. were soaring in Wednesday trading after the biotech clinched a partnership with Wegovy and Ozempic parent Novo Nordisk to collaborate on oral obesity and Type 2 diabetes ...

Biotechnology encompasses a variety of techniques that employ living cells and molecules, such as enzymes, derived from organisms to produce or alter products and processes. In the plastics sector, ...

On May 8, Michael Yee, Senior Biotech Analyst at Jefferies, appeared on CNBC to discuss how tariffs and policy risks are pressuring the biotech industry, while simultaneously iterating that low ...

CHA Biotech reported on the 14th that its consolidated revenue for the first quarter of this year was 304.1 billion won, a 31% increase compared to the same period last year. During the same ...

Central Ohio's biotech sector has exploded in just five years, with four companies now employing 1,200 people in high-paying jobs. After $600M acquisition, biotech founder finds her new venture ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top ...

Looking for the best biotech penny stocks? The most important innovation of the 1990s was the internet — today, it would be a vaccine for COVID-19. If these times have anything to say about it ...

Ph.D., MBA, Chief Executive Officer, Vir Biotechnology. "We successfully dosed the first patient in our ECLIPSE Phase 3 registrational program for hepatitis delta, a devastating disease with no ...